
Sign up to save your podcasts
Or


AT&T makes a $49 billion bid for DirecTV, while AstraZeneca turns down a $117 billion offer from Pfizer. Our analysts try to make sense of it all and offer up a couple of merger-related ideas of their own.
By The Motley Fool4.7
16041,604 ratings
AT&T makes a $49 billion bid for DirecTV, while AstraZeneca turns down a $117 billion offer from Pfizer. Our analysts try to make sense of it all and offer up a couple of merger-related ideas of their own.

3,230 Listeners

1,500 Listeners

806 Listeners

942 Listeners

531 Listeners

1,186 Listeners

2,189 Listeners

825 Listeners

1,431 Listeners

1,047 Listeners

9,717 Listeners

194 Listeners

829 Listeners

84 Listeners

589 Listeners

1,034 Listeners

50 Listeners